Plus TherapeuticsCNSY
13F holders, Q1 2024 (March 31)10holders
2famous investors
$1.80avg. 13F price*
At the end of Q1 2024, 10 institutions reported holding Plus Therapeutics Inc. (CNSY) in their 13F filings. The largest holders were Vanguard Group Inc. ($59K), Geode Capital Management, LLC ($53K) and Renaissance Technologies ($31K). 2 famous investors held it, including Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio) and Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Plus Therapeutics Inc.
- CUSIP
- 72941H509
- Latest filing quarter
- Q1 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 2 | $41K |
Ownership 10 holders
| Vanguard Group Inc. | 0.00% | No change | 32,541 | $59K |
| Geode Capital Management, LLC | 0.00% | Add +10.3% | 29,263 | $53K |
| Renaissance Technologies | 0.00% | Reduce -47.3% | 17,400 | $31K |
| Citadel Advisors | 0.00% | Reduce -36.4% | 10,709 | $19K |
| BlackRock Inc. | 0.00% | No change | 6,960 | $13K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +569.6% | 3,830 | $7K |
| Osaic Holdings, Inc. | 0.00% | No change | 133 | $240 |
| JPMorgan Chase & Co. | 0.00% | Add +1.0% | 100 | $181 |
| Wells Fargo & Company | 0.00% | No change | 35 | $63 |
| Group One Trading LLC | 0.00% | No change | 1 | $2 |
"% of holder's portfolio" is CNSY's weight in each manager's 13F, not the share of Plus Therapeutics Inc. the manager owns.